ESC 365 - Screening data correlates with inappropriate therapy occurrence after subcutaneous implantable cardioverter defibrillator implantation: a single center experience.

EHRA Premium Access

Screening data correlates with inappropriate therapy occurrence after subcutaneous implantable cardioverter defibrillator implantation: a single center experience.

Session: Poster session 2 - Implantable Cardioverter / Defibrillator

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor A. Carabelli (La Tronche, FR)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Doctor Adrien Carabelli

University Hospital of Grenoble, La Tronche (France)

0 follower

14 more presentations in this session

Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.

Speaker: Mr J. Ramos Maqueda (Zaragoza, ES)

Implantable cardioverter defibrillator and resynchronisation therapy in patients with dilated cardiomyopathy:efficiency in prevention of sudden cardiac death

Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter defibrillator.

Speaker: Associate Professor I. Diemberger (Bologna, IT)

Appropriate and inappropriate ICD therapy with evidence-based programming: a real-world comparison with trial data

Speaker: Doctor M. Chapman (Middlesbrough, GB)

Determinants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization capabilities

Speaker: Doctor R. Brenner (St. Gallen, CH)

Access the full session

Poster session 2 - Implantable Cardioverter / Defibrillator

Speakers: Doctor A. Carabelli, Mr J. Ramos Maqueda, Associate Professor I. Diemberger, Doctor M. Chapman, Doctor R. Brenner

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources